Table 3 Baseline characteristics in patients with and without primary outcome events.
Variables, n (%) | With outcome events (n = 110) | Without outcome events (n = 3621) | p value |
|---|---|---|---|
Age (yrs) | 69.7 ± 12.4 | 65.4 ± 11.2 | 0.0001 |
Gender (Male ) | 78 (70.9) | 2741 (75.7) | 0.30 |
BMI (kg/m2) | 25.5 ± 3.6 | 26.4 ± 3.7 | 0.0193 |
Cigarette smoking history | 60 (54.6) | 1676 (46.3) | 0.11 |
With anti-platelets therapy | 101 (91.8) | 3295 (91.0) | 0.90 |
With ARB/ ACEI | 72 (65.5) | 2130 (58.8) | 0.19 |
With beta-blocker | 47 (42.7) | 2171 (60.0) | < 0.0005 |
History of hypertension | 80 (72.7) | 2555 (70.6) | 0.71 |
History of heart failure | 25 (22.7) | 400 (11.1) | < 0.0005 |
History of diabetes mellitus | 52 (49.5) | 1265 (39.3) | 0.0453 |
Previous coronary/peripheral intervention | 65 (59.1) | 2203 (60.8) | 0.79 |
Coronary artery disease | 103 (93.6) | 3407 (94.1) | 0.84 |
Myocardial infarction | 96 (87.3) | 2947 (81.4) | 0.15 |
Ischemic stroke/TIA | 19 (17.3) | 380 (10.5) | 0.0349 |
Chronic kidney disease | 49 (47.1) | 858 (25.7) | < 0.0001 |
Lipid profile (mg/dL) | |||
Total cholesterol | 173.3 ± 38.8 | 167.5 ± 42.0 | 0.12 |
Triglyceride | 148.9 ± 95.4 | 137.3 ± 88.3 | 0.17 |
LDL-C | 99.1 ± 36.9 | 95.7 ± 34.1 | 0.31 |
HDL-C | 44.0 ± 13.1 | 44.9 ± 12.9 | 0.47 |
Primary outcome events | |||
Cardiovascular death | 22 (20.0) | – | |
Nonfatal stroke | 37 (33.6) | – | |
Nonfatal myocardial infarction | 44 (40.0) | – | |
Cardiac arrest with resuscitation | 7 (6.4) | – | |
